A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950) Meeting Abstract
| Authors: | Jones, R. L.; Blay, J. Y.; Agulnik, M.; Chugh, R.; Mir, O.; Italiano, A.; Thomas, D.; Gupta, A.; Jahan, T.; Cote, G.; Villalobos, V.; Demetri, G. D. D.; Roche, M.; Sapir, I.; Daigle, S.; Clawson, A.; Gounder, M. |
| Abstract Title: | A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy299.011 |
| Language: | English |
| ACCESSION: | WOS:000459277303381 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy299.011 |
| Notes: | Meeting Abstract: 1612PD -- Appears on pages viii580-viii581 of the abstract book -- Source: Wos |
